Long Non-coding RNA TMPO-AS1 Promotes Cell Proliferation, Migration, Invasion and Epithelial-to-mesenchymal Transition in Gallbladder Carcinoma by Regulating the MicroRNA-1179/E2F2 Axis

Overview

Journal Oncol Lett

Specialty Oncology

Date 2021 Nov 15

PMID 34777589

Citations 3

Authors

Zhenghui Sui

Xin Sui

Affiliations

Soon will be listed here.

Abstract

Gallbladder carcinoma (GBC), which is a common tumor of the biliary system, poses a serious threat to human life and health. The present study aimed to investigate the molecular mechanism of the long non-coding (lnc)RNA thymopoietin antisense transcript 1 (TMPO-AS1)/microRNA (miRNA/miR)-1179/E2F transcription factor 2 (E2F2) axis in GBC. The viability, proliferation, migration, invasion and epithelial-to-mesenchymal transition (EMT) of GBC cell lines were assessed via the Cell Counting Kit-8, colony formation, Transwell migration and invasion, immunofluorescence and western blot assays. In the present study, lncRNA TMPO-AS1 was significantly upregulated in clinical GBC tissues and cell lines, and was highly expressed in stage III+IV patients with GBC compared with stage I+II patients with GBC. In addition, the overall survival rate of patients with low TMPO-AS1 expression levels was higher than those with high TMPO-AS1 expression levels. Furthermore, TMPO-AS1 knockdown inhibited the viability, proliferation, migration, invasion and EMT of GBC cell lines. In addition, miR-1179 expression was downregulated in clinical GBC tissues and cell lines, and negatively correlated with TMPO-AS1 expression. The results revealed that miR-1179 is a target of TMPO-AS1, which was confirmed via the dual-luciferase reporter assay and RNA pull-down analysis. Overexpression of miR-1179 inhibited the viability, proliferation, migration, invasion and EMT of GBC cell lines. Furthermore, E2F2 was verified as a direct target of miR-1179 by binding to its 3'-untranslated region. E2F2 expression was significantly upregulated in clinical GBC tissues and cell lines, and negatively correlated with miR-1179 expression. Notably, E2F2 knockdown partially hindered the effects of TMPO-AS1/miR-1179 on the proliferation and metastasis of GBC cell lines. Taken together, the results of the present study suggest that TMPO-AS1 potentially plays a tumor-promoting role in the occurrence and development of GBC, which may be achieved by regulating the miR-1179/E2F2 axis.

Citing Articles

Competing Endogenous TMPO-AS1-let-7c-5p- LDHA RNA Network Predicts the Prognosis of Lung Adenocarcinoma Patients.

Nema R, Vats P, Singh J, Srivastava S, Kumar A Asian Pac J Cancer Prev. 2024; 25(10):3673-3689.

PMID: 39471036 PMC: 11711337. DOI: 10.31557/APJCP.2024.25.10.3673.

GBCdb: RNA expression landscapes and ncRNA-mRNA interactions in gallbladder carcinoma.

Guo L, Xiang Y, Dou Y, Yin Z, Xu X, Tang L BMC Bioinformatics. 2023; 24(1):12.

PMID: 36624399 PMC: 9830852. DOI: 10.1186/s12859-023-05133-2.

Non-coding RNAs as potential biomarkers of gallbladder cancer.

Lv Y, Yin W, Zhang Z Clin Transl Oncol. 2022; 25(6):1489-1511.

PMID: 36576705 DOI: 10.1007/s12094-022-03056-7.

A long non-coding RNA with important roles in the carcinogenesis.

Ghafouri-Fard S, Askari A, Hussen B, Taheri M, Mokhtari M Front Cell Dev Biol. 2022; 10:1037149.

PMID: 36467407 PMC: 9709449. DOI: 10.3389/fcell.2022.1037149.

References

Liang C, Yang P, Han T, Wang R, Xing X, Si A . Long non-coding RNA DILC promotes the progression of gallbladder carcinoma. Gene. 2019; 694:102-110. DOI: 10.1016/j.gene.2018.12.086. View

Vega E, Sanhueza M, Vinuela E . Minimally Invasive Surgery for Gallbladder Cancer. Surg Oncol Clin N Am. 2019; 28(2):243-253. DOI: 10.1016/j.soc.2018.11.001. View

Yao H, Lu F, Shao Y . The E2F family as potential biomarkers and therapeutic targets in colon cancer. PeerJ. 2020; 8:e8562. PMC: 7035869. DOI: 10.7717/peerj.8562. View

Mitobe Y, Ikeda K, Sato W, Kodama Y, Naito M, Gotoh N . Proliferation-associated long noncoding RNA, TMPO-AS1, is a potential therapeutic target for triple-negative breast cancer. Cancer Sci. 2020; 111(7):2440-2450. PMC: 7385350. DOI: 10.1111/cas.14498. View

Yifan T, Zheyong L, Miaoqin C, Liang S, Xiujun C . A predictive model for survival of gallbladder adenocarcinoma. Surg Oncol. 2018; 27(3):365-372. DOI: 10.1016/j.suronc.2018.05.007. View

Yang L, Cheng X, Ge N, Guo W, Feng F, Wan F . Long non-coding RNA SPRY4-IT1 promotes gallbladder carcinoma progression. Oncotarget. 2016; 8(2):3104-3110. PMC: 5356867. DOI: 10.18632/oncotarget.13621. View

Ji D, Zhong X, Jiang X, Leng K, Xu Y, Li Z . The role of long non-coding RNA AFAP1-AS1 in human malignant tumors. Pathol Res Pract. 2018; 214(10):1524-1531. DOI: 10.1016/j.prp.2018.08.014. View

Peng W, Koirala P, Mo Y . LncRNA-mediated regulation of cell signaling in cancer. Oncogene. 2017; 36(41):5661-5667. PMC: 6450570. DOI: 10.1038/onc.2017.184. View

Wang S, Zhang W, Wu X, Weng M, Zhang M, Cai Q . The lncRNA MALAT1 functions as a competing endogenous RNA to regulate MCL-1 expression by sponging miR-363-3p in gallbladder cancer. J Cell Mol Med. 2016; 20(12):2299-2308. PMC: 5134409. DOI: 10.1111/jcmm.12920. View

10.

Li Y, Qin C . MiR-1179 inhibits the proliferation of gastric cancer cells by targeting HMGB1. Hum Cell. 2019; 32(3):352-359. DOI: 10.1007/s13577-019-00244-6. View

11.

Mitobe Y, Ikeda K, Suzuki T, Takagi K, Kawabata H, Horie-Inoue K . -Stabilizing Long Noncoding RNA Promotes Hormone-Refractory Breast Cancer Progression. Mol Cell Biol. 2019; 39(23). PMC: 6851347. DOI: 10.1128/MCB.00261-19. View

12.

Castro-Oropeza R, Melendez-Zajgla J, Maldonado V, Vazquez-Santillan K . The emerging role of lncRNAs in the regulation of cancer stem cells. Cell Oncol (Dordr). 2018; 41(6):585-603. DOI: 10.1007/s13402-018-0406-4. View

13.

Sharma A, Sharma K, Gupta A, Yadav A, Kumar A . Gallbladder cancer epidemiology, pathogenesis and molecular genetics: Recent update. World J Gastroenterol. 2017; 23(22):3978-3998. PMC: 5473118. DOI: 10.3748/wjg.v23.i22.3978. View

14.

Hua C, Song S, Ma H, Li X . MiR-1-5p is down-regulated in gallbladder carcinoma and suppresses cell proliferation, migration and invasion by targeting Notch2. Pathol Res Pract. 2018; 215(1):200-208. DOI: 10.1016/j.prp.2018.10.013. View

15.

Cui H, Zhao J . LncRNA TMPO-AS1 serves as a ceRNA to promote osteosarcoma tumorigenesis by regulating miR-199a-5p/WNT7B axis. J Cell Biochem. 2019; 121(3):2284-2293. DOI: 10.1002/jcb.29451. View

16.

Hickman L, Contreras C . Gallbladder Cancer: Diagnosis, Surgical Management, and Adjuvant Therapies. Surg Clin North Am. 2019; 99(2):337-355. DOI: 10.1016/j.suc.2018.12.008. View

17.

Li X, Zhang Z, Jiang H, Li Q, Wang R, Pan H . Circular RNA circPVT1 Promotes Proliferation and Invasion Through Sponging miR-125b and Activating E2F2 Signaling in Non-Small Cell Lung Cancer. Cell Physiol Biochem. 2018; 51(5):2324-2340. DOI: 10.1159/000495876. View

18.

Guo X, Wang Y . LncRNA TMPO-AS1 promotes hepatocellular carcinoma cell proliferation, migration and invasion through sponging miR-329-3p to stimulate FOXK1-mediated AKT/mTOR signaling pathway. Cancer Med. 2020; 9(14):5235-5246. PMC: 7367632. DOI: 10.1002/cam4.3046. View

19.

Huang W, Su X, Yan W, Kong Z, Wang D, Huang Y . Overexpression of AR-regulated lncRNA TMPO-AS1 correlates with tumor progression and poor prognosis in prostate cancer. Prostate. 2018; 78(16):1248-1261. DOI: 10.1002/pros.23700. View

20.

Lin C, Hu Z, Yuan G, Su H, Zeng Y, Guo Z . MicroRNA-1179 inhibits the proliferation, migration and invasion of human pancreatic cancer cells by targeting E2F5. Chem Biol Interact. 2018; 291:65-71. DOI: 10.1016/j.cbi.2018.05.017. View